Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94854705 | 9485470 | 5 | F | 20131003 | 20160913 | 20130829 | 20160915 | EXP | CA-ROCHE-1267353 | ROCHE | 49.92 | YR | M | Y | 0.00000 | 20160915 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94854705 | 9485470 | 1 | PS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | DAYS 1 AND 15 | N | B34200,B00019,H0760B02 | 103705 | 1000 | MG | SOLUTION FOR INFUSION | |||||
| 94854705 | 9485470 | 2 | SS | RITUXAN | RITUXIMAB | 1 | N | B34200,B00019,H0760B02 | 103705 | ||||||||||
| 94854705 | 9485470 | 3 | SS | GLUCONORM (CANADA) | REPAGLINIDE | 1 | Unknown | U | 0 | ||||||||||
| 94854705 | 9485470 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | U | 0 | ||||||||||
| 94854705 | 9485470 | 5 | C | IMURAN | AZATHIOPRINE | 1 | 0 | ||||||||||||
| 94854705 | 9485470 | 6 | C | FOSAMAX | ALENDRONATE SODIUM | 1 | 0 | ||||||||||||
| 94854705 | 9485470 | 7 | C | HYZAAR | HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM | 1 | 0 | ||||||||||||
| 94854705 | 9485470 | 8 | C | DIPHENHYDRAMINE HCL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Oral | 0 | 50 | MG | |||||||||
| 94854705 | 9485470 | 9 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Oral | 0 | 650 | MG | |||||||||
| 94854705 | 9485470 | 10 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 94854705 | 9485470 | 11 | C | METHOTREXATE. | METHOTREXATE | 1 | 0 | ||||||||||||
| 94854705 | 9485470 | 12 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 94854705 | 9485470 | 13 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Intravenous (not otherwise specified) | 0 | 100 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 94854705 | 9485470 | 1 | Dermatomyositis |
| 94854705 | 9485470 | 2 | Off label use |
| 94854705 | 9485470 | 3 | Type 2 diabetes mellitus |
| 94854705 | 9485470 | 4 | Product used for unknown indication |
| 94854705 | 9485470 | 8 | Premedication |
| 94854705 | 9485470 | 9 | Premedication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 94854705 | 9485470 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 94854705 | 9485470 | Asthenia | |
| 94854705 | 9485470 | Blood glucose increased | |
| 94854705 | 9485470 | Blood pressure increased | |
| 94854705 | 9485470 | Infusion related reaction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 94854705 | 9485470 | 1 | 20100909 | 0 | ||
| 94854705 | 9485470 | 8 | 20100909 | 0 | ||
| 94854705 | 9485470 | 9 | 20100909 | 0 | ||
| 94854705 | 9485470 | 13 | 20130919 | 0 |